Hesham Abboud, MD
- Director, Multiple Sclerosis and Neuroimmunology Program, UH Cleveland Medical Center
- Associate Professor, CWRU School of Medicine
- Specialty: Neurology-Movement Disorders, Neurology-Neuroimmunology
-
Location:UH Suburban Health Center
1611 S Green Rd
South Euclid, OH 44121
- Call: 216-844-8685
Biography: Hesham Abboud, MD
Expertise
Certifications & Memberships
- Neurology - American Board of Psychiatry and Neurology
Education
Fellowship | Neuroimmunology
Neuroimmunology - Cleveland Clinic (2015 - 2016)
Residency | Neurology
Neurology - Cleveland Clinic (2011 - 2015)
Fellowship | Movement Disorders
Movement Disorders - Cleveland Clinic (2009 - 2011)
Residency | Neurology
Neurology - Alexandria University Hospitals (2004 - 2007)
Medical Education
Alexandria University (2002)
About
View Dr. Abboud’s Health TalksHesham Abboud, MD, PhD is the Director of the Multiple Sclerosis and Neuroimmunology Program at University Hospitals and a staff neurologist at the Parkinson's and Movement Disorders Center. He is an Associate Professor of Neurology at Case Western Reserve University School of Medicine. Dr. Abboud is board-certified in neurology. His special interests include Multiple Sclerosis, neuromyelitis optica, autoimmune encephalitis, autoimmune movement disorders, spinal movement disorders, spasticity management, and neuromodulation.
Dr. Abboud earned his medical degree from Alexandria University in Egypt, where he also completed an internship and a residency in Neurology and Psychiatry. He obtained his Masters and Doctorate degrees in Neurology from Alexandria University before joining the Cleveland Clinic. He completed a residency in adult neurology, a clinical fellowship in movement disorders and neuromodulation, and a clinical fellowship in multiple sclerosis and neuroimmunology, all at the Cleveland Clinic. Dr. Abboud received special training in transverse myelitis and neuromyelitis optica at the Transverse Myelitis Center of Johns Hopkins University.
Dr. Abboud is invested in medical education. He was selected as the medical student liaison for Neurology clerkship at the Cleveland Clinic during his residency. He was appointed as a clinical instructor of neurology at the Cleveland Clinic Lerner College of Medicine. He received the Trainee Teacher of Year Award, the Excellence in Teaching Award from the Cleveland Clinic in 2015, and the UH Excellence in Neurology Teaching Award in 2020.
Dr. Abboud has written several peer-reviewed articles, abstracts, and book chapters focusing on neuroimmunology and movement disorders. He has presented his research at many international and national conferences. He has won several research awards and travel grants from professional societies like the American Academy of Neurology, the American Committee for Treatment and Research in Multiple Sclerosis, the Consortium of Multiple Sclerosis Centers, and The International Movement Disorders Society. Dr. Abboud has also served as a reviewer for many prominent medical journals focusing on general neurology, neuroimmunology, and movement disorders. He is a member of the American Academy of Neurology, The Consortium of Multiple Sclerosis Centers, the NMO International Clinical Consortium, the Autoimmune Encephalitis Alliance, and the Movement Disorder Society.
Research & Publications
Research Interests
Neuroimmunology: Multiple sclerosis, NMO, transverse myelitis, autoimmune/paraneoplastic encephalitis | Movement disorders: autoimmune movement disorders, spinal movement disorders, spasticity, Parkinson's disease, dystonia, tremors | Neuromodulation and DBS
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Hesham Abboud did not disclose any Outside Relationships with Industry.